|Bid||20.21 x 1800|
|Ask||20.22 x 1200|
|Day's range||20.07 - 20.33|
|52-week range||12.96 - 23.30|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||12 May 2022|
|1y target est||19.75|
Philips (PHG) launches three MR Smart Fit coils, namely TorsoCardiac 1.5T, 1.5T shoulder and Knee 3.0T, enhancing flexibility, reducing patient setup time and improving image quality resolution.
Royal Philips's (PHG) strategic transformation from consumer electronics to healthcare innovation is well underway. The company's goal is to improve the lives of three billion people a year by 2025. But the transition has been a bumpy ride for investors. Shares of the Dutch manufacturer have slumped amid a recall of its sleep apnea devices. Royal Philips CEO Roy Jakobs joins Yahoo Finance Live to discuss the recalls as well as the company's measured adoption of AI-powered solutions. "We do it in a responsible manner... The National Academy of Medicine has gathered tech companies, providers, regulators and government officials to develop a code of conduct for responsible AI application," Jakobs said. "AI can come to the rescue but, of course, you need to be aware of what it can and cannot do." Jakobs added: "The closer you get to the patient, the more careful you need to be." Click here to watch the full interview on the Yahoo Finance YouTube page or you can watch this full episode of Yahoo Finance Live here.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the Singapore findings of its Future Health Index (FHI) 2023 report: Taking Healthcare Everywhere, which shows that Singapore's health sector is at the forefront of digital technology adoption to address healthcare workforce challenges and improve efficiencies in healthcare delivery across healthcare settings (from hospital to home and into the community), benefitting both patients and healthcare staff wh